The neuropathology, medical management and dental implications of autism

被引:71
作者
Friedlander, Arthur H. [1 ]
Vagiela, John A. [1 ]
Paterno, Victoria I. [1 ]
Mahler, Michael E. [1 ]
机构
[1] VA Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA
关键词
autism; neurodevelopmental disorders; Asperger's syndrome; pervasive developmental disorder; adverse effects; dental treatment;
D O I
10.14219/jada.archive.2006.0086
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Background. A paucity of information exists in the dental literature about autism and its dental implications. Types of Studies Reviewed. The authors conducted a MEDLINE search for the period 2000 through 2006, using the term "autism," with the aim of defining the condition's clinical manifestations, dental and medical treatment and dental implications. Results. Autism is a severe developmental. brain disorder that appears in infancy, persists throughout life, and is characterized by impaired social interaction, abnormalities in communication (both verbal and nonverbal and restricted interests. Often accompanying the disorder are behavioral disturbances-such as self-mutilation, aggression, psychiatric symptoms and seizures-that necessitate the administration of multiple medications to help the affected person participate effectively in the educational and rehabilitative process. Clinical Implications. Dentists caring for people with autism must be familiar with the manifestations of the, disease and its associated features so that they can garner the maximum level of patient cooperation. They also must be familiar with the medications used to treat the associated features of the disorder because many of them cause untoward orofacial and systemic reactions and may precipitate adverse interactions with dental therapeutic agents.
引用
收藏
页码:1517 / 1527
页数:11
相关论文
共 104 条
[1]   Cerebellar function-in autism:: Functional magnetic resonance image activation during a simple motor task [J].
Allen, G ;
Müller, RA ;
Courchesne, E .
BIOLOGICAL PSYCHIATRY, 2004, 56 (04) :269-278
[2]   Prevalence and patterns of use of psychoactive medicines among individuals with autism in the Autism Society of Ohio [J].
Aman, MG ;
Lam, KSL ;
Collier-Crespin, A .
JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, 2003, 33 (05) :527-534
[3]  
Aman Michael G, 2004, Semin Pediatr Neurol, V11, P225, DOI 10.1016/j.spen.2004.07.006
[4]  
American Psychiatric Association, 2013, DIAGN STAT MAN MENT, Vfifth, DOI [10.1176/appi.books, DOI 10.1176/APPI.BOOKS.9780890425596]
[5]  
Ananthanarayan C, 1998, Anesth Prog, V45, P12
[6]  
[Anonymous], 1992, MIEDZ KLAS CHOR PROB
[7]  
Armstrong D, 1999, Spec Care Dentist, V19, P72, DOI 10.1111/j.1754-4505.1999.tb01371.x
[8]   AUTISM AS A STRONGLY GENETIC DISORDER - EVIDENCE FROM A BRITISH TWIN STUDY [J].
BAILEY, A ;
LECOUTEUR, A ;
GOTTESMAN, I ;
BOLTON, P ;
SIMONOFF, E ;
YUZDA, E ;
RUTTER, M .
PSYCHOLOGICAL MEDICINE, 1995, 25 (01) :63-77
[9]   A screening instrument for autism at 18 months of age: A 6-year follow-up study [J].
Baird, G ;
Charman, T ;
Baron-Cohen, S ;
Cox, A ;
Swettenham, J ;
Wheelwright, S ;
Drew, A .
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2000, 39 (06) :694-702
[10]   Screening and surveillance for autism and pervasive developmental disorders [J].
Baird, G ;
Charman, T ;
Cox, A ;
Baron-Cohen, S ;
Swettenham, J ;
Wheelwright, S ;
Drew, A .
ARCHIVES OF DISEASE IN CHILDHOOD, 2001, 84 (06) :468-475